本文選題：卵巢子宮內(nèi)膜異位癥　切入點：不孕癥　出處：《青島大學(xué)》2017年碩士論文

【摘要】：目的:觀察兩個標(biāo)記基因含黃素單氧化酶3(FMO3,在輸卵管上皮組織高表達(dá))、腦惡性腫瘤缺失基因(DMBT1,在子宮內(nèi)膜組織高表達(dá))分別在卵巢子宮內(nèi)膜異位癥(EMs)不孕患者和已育患者異位病灶組織及正常卵巢組織中m RNA和蛋白表達(dá)水平,探討卵巢子宮內(nèi)膜異位癥的異位病灶組織不同來源是否與其相關(guān)性不孕有關(guān)。方法:收集2014年4月~2015年8月期間在青島大學(xué)附屬醫(yī)院住院手術(shù)治療患者,90例卵巢子宮內(nèi)膜異位癥患者根據(jù)是否伴有不孕分為卵巢EMs+不孕(40例)、卵巢EMs+已育(50例),兩組異位病灶組織分別作為觀察組和對照組。取因子宮肌瘤手術(shù)的35例患者正常卵巢組織作為正常組。采用Real-Time PCR法檢測FMO3、DMBT1m RNA表達(dá)水平,采用Western blotting法檢測FMO3、DMBT1蛋白表達(dá)水平。結(jié)果:1.觀察組中兩個標(biāo)記基因FMO3、DMBT1在m RNA上表達(dá)水平均高于正常組,DMBT1上調(diào)為正常組的22.073-53.097(平均為33.953)倍,FMO3上調(diào)為正常組的2.058-6.096(平均為4.793)倍,且差異均有顯著的統(tǒng)計學(xué)意義(P均0.05);2.對照組中僅有DMBT1在m RNA表達(dá)水平高于正常組,上調(diào)水平為正常組的5.892-12.436(平均為9.619)倍,兩者間的差異有顯著的統(tǒng)計學(xué)意義(P0.05)。FMO3在m RNA表達(dá)水平無明顯增加,表達(dá)為正常組的1.501-2.131(平均為1.816)倍,兩者間無顯著的統(tǒng)計學(xué)意義(P0.05);3.觀察組與對照組相比,觀察組FMO3在m RNA表達(dá)水平明顯升高,上調(diào)為1.738-8.500(平均為3.847)倍,差異有顯著的統(tǒng)計學(xué)意義(P0.05)。DMBT1在m RNA的上調(diào)倍數(shù)為1.013-4.514(平均2.116),但其兩組間的差異無顯著的統(tǒng)計學(xué)意義(P0.05);4.與正常組DMBT1、FMO3的蛋白表達(dá)水平(分別為0.726-0.843(平均為0.780)、0.659-0.723(平均為0.699))相比,觀察組中DMBT1、FMO3的蛋白表達(dá)水平均明顯升高,分別為1.834-2.756(平均為1.600)、1.143-1.356(平均為1.259),且差異均具有顯著的統(tǒng)計學(xué)意義;5.與正常組相比,對照組中DMBT1的蛋白表達(dá)水平明顯升高,其表達(dá)水平為1.565-2.286(平均為1.400),差異有明顯的統(tǒng)計學(xué)意義(P0.05)。FMO3蛋白表達(dá)水平為0.826-0.941(平均為0.880),兩組中的表達(dá)水平無顯著差異(P0.05);6.實驗組與對照組相比,FMO3的蛋白表達(dá)水平明顯升高,且差異具有顯著的統(tǒng)計學(xué)意義(P0.05)。DMBT1的蛋白表達(dá)水平在兩者間無明顯區(qū)別,其差異不具有顯著的統(tǒng)計學(xué)意義(P0.05)。結(jié)論:卵巢EMs相關(guān)性不孕患者的異位病灶組織高表達(dá)FMO3、DMBT1,提示不孕患者的異位病灶組織來源可能為輸卵管上皮組織和子宮內(nèi)膜組織;卵巢EMs合并已育患者異位病灶組織僅高表達(dá)DMBT1,FMO3的表達(dá)無明顯升高,提示已育患者異位病灶組織可能來源為子宮內(nèi)膜組織;輸卵管組織來源的異位內(nèi)膜組織可能與卵巢Ems患者不孕有關(guān)。
[Abstract]:Objective: to observe the expression of two marker genes, FMO3, in epithelial tissue of fallopian tube, and in ovarian endometriosis (EMs), respectively, and the deletion gene of DMBT1 in malignant tumor of brain (high expression in endometrial tissue); The expression level of m RNA and protein in ectopic focus tissue and normal ovarian tissue were detected. To investigate whether different sources of ectopic focus tissue in endometriosis of ovary are related to its associated infertility. Methods: from April 2014 to August 2015, 90 patients with ovarian cancer were treated by surgical treatment in Qingdao University affiliated Hospital. According to whether endometriosis is accompanied by infertility, 40 cases of ovarian EMs infertility and 50 cases of ovarian EMs have been divided into two groups: observation group and control group. 35 patients with uterine leiomyoma were treated as normal. Real-Time PCR assay was used to detect the expression of DMBT1m RNA in ovarian tissues. Western blotting method was used to detect the expression of FMO3 / DMBT1 protein. Results: 1. The expression level of two marker genes FMO3 / DMBT1 on m RNA in the observation group was higher than that in the normal group (22.073-53.097 (mean 33.953)) and the expression of FMO3 was 2.058-6.096 (mean 4.793) times higher than that in the normal group. The expression of DMBT1 in the control group was higher than that in the normal group, and the upregulation level was 5.892-12.436 (9.619) times higher than that in the normal group. There was no significant difference between the two groups in the expression level of m RNA, which was 1.501-2.131 times of normal group (average 1.816), and no significant statistical significance was found between the two groups. Compared with the control group, the expression of P0.05FMO3 in the observation group was higher than that in the control group, and there was no significant difference between the two groups. In the observation group, the expression of FMO3 in m RNA was significantly increased by 1.738-8.500 (mean 3.847) times. There was significant difference in the upregulation multiple of P0.05N. DMBT1 in m RNA (mean 2.116), but there was no significant difference between the two groups. The protein expression level of DMBT1 / FMO3 was 0.726-0.843 (mean 0.7800.659-0.723) in the normal group, but there was no significant difference between the two groups. The protein expression level of DMBT1 / FMO3 was significantly increased in the observation group (1.834-2.756 (mean 1.600-1.356), and the difference was significant statistically significant (P < 0.05). Compared with the control group, the expression of DMBT1 protein in the control group was significantly higher than that in the control group. The expression level of FMO3 was 1.565-2.286 (average 1.400), and the difference was significant (P 0.05) .FMO3 protein expression was 0.826-0.941 (mean 0.880). There was no significant difference between the two groups (P 0.05). Compared with the control group, the expression level of FMO3 in the experimental group was significantly higher than that in the control group, and the expression level of FMO3 in the experimental group was significantly higher than that in the control group, and the expression of FMO3 in the experimental group was significantly higher than that in the control group. There was no significant difference in the protein expression of P0.05U. DMBT1 between the two groups. Conclusion: the expression of FMO3 and DMBT1 in the ectopic lesions of patients with ovarian EMs associated infertility is high, suggesting that the ectopic lesions of infertile patients may originate from the tubal epithelial tissue and endometrial tissue. The expression of DMBT1FMO3 was not significantly increased in ovarian EMs complicated with ectopic lesions, suggesting that the ectopic focus tissues of fertile patients may originate from endometrial tissue. Ectopic endometrial tissue derived from oviduct tissue may be associated with infertility in patients with ovarian Ems.
【學(xué)位授予單位】：青島大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R711.71;R711.6

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 郭蕊萌;孫惠淼;;氧化應(yīng)激對子宮內(nèi)膜異位癥患者在位內(nèi)膜容受性的影響[J];現(xiàn)代婦產(chǎn)科進(jìn)展;2016年12期

2 陳敏;王遠(yuǎn)菊;王彩霞;;腹腔鏡下卵巢子宮內(nèi)膜異位囊腫剝除術(shù)前使用GnRH-a預(yù)處理對卵巢儲備功能的影響[J];現(xiàn)代婦產(chǎn)科進(jìn)展;2016年10期

3 馮雪;宋永;周敏;肖麗;朱慧莉;黃薇;;子宮內(nèi)膜異位癥裸鼠模型子宮內(nèi)膜的雌、孕激素受體表達(dá)[J];現(xiàn)代婦產(chǎn)科進(jìn)展;2016年02期

4 李安吉;俞超芹;;子宮內(nèi)膜異位癥患者卵泡液微環(huán)境與不孕癥發(fā)生相關(guān)性研究進(jìn)展[J];生殖醫(yī)學(xué)雜志;2016年01期

5 鄭軒;林勤;王澍穎;;同源框基因A10在子宮內(nèi)膜異位癥患者子宮內(nèi)膜組織中的表達(dá)[J];中華全科醫(yī)學(xué);2015年12期

6 魏利;吳凱彥;王軼英;;卵巢子宮內(nèi)膜異位癥的輸卵管起源及其臨床意義[J];實用婦產(chǎn)科雜志;2015年11期

7 代娟娟;曾荔蘋;湯惠茹;宋曉蕾;鐘煥姿;賈慧玨;吳瑞芳;;子宮內(nèi)膜異位癥不孕女性腹腔液菌群構(gòu)成及TNF-α與IL-37水平研究[J];中國婦產(chǎn)科臨床雜志;2015年05期

8 鄭婷萍;孫愛軍;郎景和;鄧燕;陳蓉;田秦杰;鄧姍;;北京協(xié)和醫(yī)院住院患者不孕癥與子宮內(nèi)膜異位癥30年變化趨勢[J];中華婦產(chǎn)科雜志;2015年08期

9 李日紅;陳光元;謝家濱;鄧惠宜;;β-內(nèi)啡肽和泌乳素分泌紊亂在子宮內(nèi)膜異位癥不孕中的影響及相關(guān)性研究[J];河北醫(yī)藥;2015年15期

10 宋亞麗;全松;;子宮內(nèi)膜異位癥患者內(nèi)膜容受性及“種植窗”的特點[J];生殖與避孕;2014年07期

，

本文編號：1668527